Mode
Text Size
Log in / Sign up
N/A N=10 Treatment

Effects of an Overground Propulsion Neuroprosthesis in Community-dwelling Individuals After Stroke

Stroke

Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcome: Primary: Immediate Change in Walking Speed — 0.01; 0.03 meters per second (m/s)

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Propulsion Neuroprosthesis (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Boston University Charles River Campus
Primary completion
May 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Immediate Change in Walking Speed
0.00; 0.03 0.131
PRIMARY
Immediate Change in Paretic Propulsion
-0.36; 1.41 0.001 sig
PRIMARY
Immediate Change in Propulsion Symmetry
-2.13; 1.19 0.017 sig
PRIMARY
Immediate Change in Walking Speed
0.00; 0.03 0.131
PRIMARY
Immediate Change in Paretic Propulsion
-0.36; 1.41 0.001 sig
PRIMARY
Immediate Change in Propulsion Symmetry
-2.13; 1.19 0.017 sig
PRIMARY
Immediate Change in Walking Speed
0.00; 0.03 0.131
PRIMARY
Immediate Change in Paretic Propulsion
-0.36; 1.41 0.001 sig
PRIMARY
Immediate Change in Propulsion Symmetry
-2.13; 1.19 0.017 sig
PRIMARY
Immediate Change in Walking Speed
0.00; 0.03 0.131
PRIMARY
Immediate Change in Paretic Propulsion
-0.36; 1.41 0.001 sig
PRIMARY
Immediate Change in Propulsion Symmetry
-2.13; 1.19 0.017 sig
PRIMARY
Walking Speed at Non-Preferred Timing
1.30; 1.30 0.874
PRIMARY
Paretic Propulsion at Non-Preferred Timing
12.19; 11.83 0.345
PRIMARY
Propulsion Symmetry at Non-Preferred Timing
32.2; 30.0 0.024 sig
PRIMARY
Walking Speed at Preferred Timing
1.31; 1.34 0.044 sig
PRIMARY
Paretic Propulsion at Preferred Timing
11.87; 13.28 0.017 sig
PRIMARY
Propulsion Symmetry at Preferred Timing
31.8; 33.0 0.372
PRIMARY
Unassisted Fast Walking Speed
1.24; 1.38 0.001 sig
PRIMARY
Unassisted Paretic Propulsion at Fast Speed
11.20; 13.44 0.043 sig
PRIMARY
Unassisted Propulsion Symmetry at Fast Speed
28.7; 33.2 0.041 sig
PRIMARY
Unassisted Comfortable Walking Speed
0.93; 1.06 0.013 sig
PRIMARY
Unassisted Paretic Propulsion at Comfortable Speed
8.50; 10.12 0.012 sig
PRIMARY
Unassisted Propulsion Symmetry at Comfortable Speed
28.4; 33.2 0.036 sig
SECONDARY
Onset Timing of Plantarflexor Neurostimulation
46.9; 63.7
SECONDARY
Preferred Neurostimulation Timing
5; 5
SECONDARY
Dorsiflexion Angle (No Dorsiflexor Impairment)
4.50; 5.15; 5.14
SECONDARY
Dorsiflexion Angle (With Dorsiflexor Impairment)
-3.61; 0.13; -1.03
SECONDARY
Immediate Change in Dorsiflexion Angle
1.48; 1.46 0.962
SECONDARY
Immediate Change in Plantarflexor Power
0.13; 0.27 0.146
SECONDARY
Dorsiflexion Angle at Non-Preferred Timing
2.16; 3.64 0.152
SECONDARY
Plantarflexor Power at Non-Preferred Timing
1.88; 2.00 0.153
SECONDARY
Dorsiflexion Angle at Preferred Timing
1.83; 3.29 0.155
SECONDARY
Plantarflexor Power at Preferred Timing
1.84; 2.11 0.004 sig
SECONDARY
Unassisted Dorsiflexion Angle at Fast Speed
2.85; 0.66 0.014 sig
SECONDARY
Unassisted Plantarflexor Power at Fast Speed
1.78; 1.98 0.350
SECONDARY
Unassisted Dorsiflexion Angle at Comfortable Speed
2.07; 0.27 0.052
SECONDARY
Unassisted Plantarflexor Power at Comfortable Speed
1.25; 1.39 0.221

Summary

This interventional study evaluates the effects of an overground propulsion neuroprosthesis that delivers adaptive neurostimulation assistance to the paretic plantarflexors and dorsiflexors of people post-stroke. Individuals with chronic post-stroke hemiparesis will walk with and without the neuroprosthesis overground and on a treadmill. The goal of the study is to understand how adaptive neurostimulation delivered by the neuroprosthesis affects clinical and biomechanical measures of walking function in order to guide future rehabilitation approaches for restoring walking ability after stroke.

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of a stroke event occurring at least 6 months ago
  • Observable gait deficits
  • Independent ambulation for at least 30 meters (using an assistive device as needed but without a rigid brace or ankle foot orthosis)
  • Passive ankle dorsiflexion range of motion to neutral with the knee extended
  • Ability to follow a 3-step command
  • Resting heart rate between 40-100 bpm
  • Resting blood pressure between 90/60 and 170/90 mmHg
  • NIH Stroke Scale Question 1b score > 1 and Question 1c score > 0
  • HIPAA Authorization to allow communication with healthcare provider
  • Medical clearance by a physician

Exclusion Criteria

  • Severe aphasia or inability to communicate with investigators
  • Neglect or hemianopia
  • Serious comorbidities that may interfere with ability to participate in the research (e.g. musculoskeletal, cardiovascular, pulmonary)
  • Pacemakers or similar electrical implants that could be affected by electrical stimulation
  • Metal implants directly under the stimulation sites
  • Pressure ulcers or skin wounds located near human-device interface sites
  • More than 2 unexplained falls in the previous month
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06459401). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search